Therapy of malignant APUD cell tumors: Effectiveness of DTIC (Q40132855)

reason for preferred rank

17 September 2017

Therapy of malignant APUD cell tumors: Effectiveness of DTIC (English)

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

Therapy of malignant APUD cell tumors. Effectiveness of DTIC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295614

19 September 2023

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

author name string

A. Kessinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295614

19 September 2023

J. F. Foley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295614

19 September 2023

H. M. Lemon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295614

19 September 2023

language of work or name

English

0 references

publication date

1 March 1983

1 reference

full work available at URL

17 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819830301%2951%3A5%3C790%3A%3AAID-CNCR2820510507%3E3.0.CO%3B2-3

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295614

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

1 reference

17 September 2017

51

1 reference

17 September 2017

5

1 reference

17 September 2017

790-794

1 reference

The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept

17 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830301%2951%3A5%3C790%3A%3AAID-CNCR2820510507%3E3.0.CO%3B2-3

Adriamycin. A new anticancer drug with significant clinical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830301%2951%3A5%3C790%3A%3AAID-CNCR2820510507%3E3.0.CO%3B2-3

Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830301%2951%3A5%3C790%3A%3AAID-CNCR2820510507%3E3.0.CO%3B2-3

Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830301%2951%3A5%3C790%3A%3AAID-CNCR2820510507%3E3.0.CO%3B2-3

Dimethyltriazenoimidazole Carboxamide Therapy of Malignant Glucagonoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830301%2951%3A5%3C790%3A%3AAID-CNCR2820510507%3E3.0.CO%3B2-3

Neuroendocrine neoplasms and their cells of origin

21 January 2018

2

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

4

60

123

Schepartz

1976

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

6

60

141

Bono

1976

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

7

61

101

Kessinger

1977

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

The glucagonoma syndrome and its management

19 September 2023

8

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

10

60

273

Solomon

1976

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

Treatment of bronchogenic carcinoma. II. Small cell

19 September 2023

11

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

12

60

939

Knight

1976

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

19 September 2023

13

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma

19 September 2023

15

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

Malignant Glucagonoma Syndrome: Response to Chemotherapy

19 September 2023

20

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

A familial glucagonoma syndrome: genetic, clinical and biochemical features

19 September 2023

21

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

23

60

189

Costanzi

1976

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

24

60

165

Comis

1976

1 reference

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(19830301)51:5%3C790::AID-CNCR2820510507%3E3.0.CO;2-3

19 September 2023

Identifiers

10.1002/1097-0142(19830301)51:5<790::AID-CNCR2820510507>3.0.CO;2-3

1 reference

17 September 2017

1 reference